Brookdale Files Investor Presentation Highlighting Board's Effective Oversight of Clear, Compelling Strategy to Deliver Long-Term Shareholder Value
Prnewswire· 2025-06-11 20:05
Brookdale's Significantly Refreshed Board Has Critical Skillsets and Experience Necessary to Drive the Company's SuccessOrtelius' Attempt to Take Control of the Company Risks Value Destruction, Disrupting Brookdale's Continued Operational Progress and CEO Search Ortelius Does Not Have a Substantially Different Strategic Plan or a Board Slate with a Diversified Skillset Relevant to Brookdale's StrategyThe Company Urges Shareholders to Vote "FOR" ONLY the Eight Brookdale Nominees Listed on the BLUE Proxy Card ...
Red Robin Gourmet Burgers, Inc. to Participate at the 15th Annual Jefferies Consumer Conference
Prnewswire· 2025-06-11 20:05
ENGLEWOOD, Colo., June 11, 2025 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a full-service restaurant chain serving an innovative selection of high-quality gourmet burgers in a family-friendly atmosphere, today announced that it will host meetings with institutional investors at the 15th Annual Jefferies Consumer Conference on June 17-18, 2025 in Nantucket, MA.About Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB)Red Robin Gourmet Burgers, Inc. (www.redrobin. ...
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
Globenewswire· 2025-06-11 20:05
CAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced the appointment of Claire Mazumdar, Ph.D., to the Company’s Board of Directors, effective June 9, 2025. “It is a privilege to welcome Claire to our Board, where she will draw from her strategic and operational experience in clinical-stage oncology ...
Toll Brothers Announces New Luxury Home Community Coming Soon to Rockwall County, Texas
Globenewswire· 2025-06-11 20:02
Toll Brothers at Ridge Pointe Estates will feature expansive floor plans on one-acre home sites near DallasMCLENDON-CHISHOLM, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Dallas-area community, Toll Brothers at Ridge Pointe Estates, is coming soon to Rockwall County, Texas. This exclusive Toll Brothers neighborhood will feature an intimate collection of new single-family homes on expansive one-acre home site ...
Quantum Rivalry Rises With IBM's Push: Is D-Wave Still a Buy?
ZACKS· 2025-06-11 20:01
Key Takeaways QBTS shares jumped 1359.5% on strong results, AI momentum, and a quantum supremacy milestone. D-Wave achieved real-world quantum supremacy using its 1,200-qubit Advantage2 prototype system. IBM's launch of Quantum Starling signals rising pressure on smaller rivals like QBTS in the quantum race.Shares of D-Wave Quantum (QBTS) have captured the spotlight over the past year, soaring an astounding 1359.5%. This rally has been fueled by accelerating demand for quantum technology, broader AI-drive ...
Is Intel the Turnaround Stock of 2025 and a Buy Now?
ZACKS· 2025-06-11 20:01
Key Takeaways INTC surged 10% as Lip-Bu Tan's CEO appointment fuels hopes for a turnaround in 2025. Intel's $50B chip facility upgrades and U.S. presence offer resilience amid trade tensions. Despite Q1 revenue of $12.7B, INTC's -36.2% profit margin signals ongoing financial strain.Intel Corporation (INTC) stock plunged 70% post chip foundry venture, yet Lip-Bu Tan’s appointment as new CEO and recent 10% stock rise hint at a potential turnaround. Is it a good buy now? Let’s see. Intel May Rebound in 2025 ...
Insmed Announces Proposed $650 Million Public Offering of Common Stock
Prnewswire· 2025-06-11 20:01
BRIDGEWATER, N.J., June 11, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it intends to offer and sell $650 million of shares of its common stock in an underwritten public offering. In addition, Insmed intends to grant the underwriters a 30-day option to purchase up to an additional $97.5 million of shares of common ...
Capital Southwest Announces Transition to Monthly Regular Dividends and Declares Total Dividends of $0.64 per share for the Quarter Ending September 30, 2025
Globenewswire· 2025-06-11 20:01
DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to announce a change to its regular dividend payment frequency from quarterly to monthly beginning in July 2025. In addition, the Company is pleased to announce that its Board of Directors has declared mont ...
Churchill Downs Incorporated 2025 Second Quarter Financial Results Conference Call Invitation
Globenewswire· 2025-06-11 20:01
LOUISVILLE, Ky., June 11, 2025 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release second quarter 2025 financial results after the market closes on Wednesday, July 23, 2025, and host a related conference call to discuss the quarter on Thursday, July 24, 2025, at 9 a.m. ET. Investors and other interested parties may listen to the call by accessing the online, real-time webcast at http://ir.churchilldownsincorporated.com/events.cfm or by regi ...
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
GlobeNewswire News Room· 2025-06-11 20:01
BEDFORD, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced the presentation of new data highlighting two oncology radiodiagnostic agents will be presented at the upcoming 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, taking place June 21-24, 2025, in New Orleans, LA. Prese ...